drugset / Trial / NCT07441486
A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
Objective: To explore the curative effect and safty of Changchun Ruibin metronomic chemotherapy combined with endistat in the treatment of HR positive HER2 negative advanced breast carcinoma.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2026-04-10
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entinostat | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | — | Oral |